Expressing the sense of the House of Representatives that policies governing access to medication abortion care in the United States should be equitable and based on science.
Active· Referred to the Subcommittee on Health.
Introduced
Aug 17, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Introduced
Aug 17, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Executive Summary
This resolution expresses the sense of the House of Representatives that policies concerning medication abortions should be grounded in science, be based on a review of medical evidence, and ensure equitable access for patients.
Action Timeline
4
AUG 18, 2021•Committee
Referred to the Subcommittee on Health.
AUG 17, 2021•IntroReferral
Introduced in House
AUG 17, 2021•IntroReferral
Introduced in House
AUG 17, 2021•IntroReferral
Referred to the House Committee on Energy and Commerce.